Assess pricing and reimbursement opportunities for metastatic gastric cancer treatment

Assess pricing and reimbursement opportunities for metastatic gastric cancer treatment

Challenge

Our client wanted to identify key payer value drivers and thresholds in metastatic gastric cancer treatments, evaluating pricing and reimbursement opportunities for a new product launch in the US and EU5.

The right stakeholder, the right channels

We used our strong connections with European and US Payers to recruit the KOLs and hospital pharmacy directors from across the EU5 and US who make the key decisions on guidelines, market access, pricing and reimbursement of drugs and treatments in each market. This was at a time when such stakeholders were considered impossible to recruit.

The right result

We successfully accessed the required different levels of stakeholders in each market within a strict timeline. The client commented:

Lightspeed All Global and their team have provided outstanding work with a very quick turnaround. The results were great and the level of the stakeholders they had access to was impressive.